trial

Effects of Pentazocine Versus Lorazepam on Manic Symptoms

NCTId NCT00431184
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 19 (actual)
Sponsored by Mclean Hospital
Primary completion 2011-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
19 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2007-01
Primary completion
2011-03
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
PentazocineLorazepam

Sponsors

Mclean HospitalLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

1
Beth L Murphy, MD/PhDPrincipal Investigator

Sites

1 total
Belmont, United States

Linked catalysts

1
Effects of Pentazocine Versus Lorazepam on Manic Symptoms — primary completion2011-03

Facts & assertions

4 sourced
Enrollment
19
Phase
PHASE2
Primary Completion Date
2011-03
Status
COMPLETED
relationships
The graph out of here
drug
Pentazocine
drug
Lorazepam
drug
lead_sponsor
Mclean Hospital
company
collaborator
Stanley Medical Research Institute
company
indication
Mania
indication
Bipolar Disorder
indication
Mania
indication
investigator
Beth L Murphy, MD/PhD
person